Group 1 - TaiLong Pharmaceutical's controlling shareholder has made significant progress in planning the transfer of company shares, with an agreement reached to transfer 8.73% of the company's total shares to Jiangyao Holdings at a price of 11.043 yuan per share, totaling 553 million yuan [1] - The transfer of control to Jiangyao Holdings is expected to inject resources into TaiLong Pharmaceutical's core business, although it is subject to government approval and subsequent integration actions [1] Group 2 - Minsheng Health announced its first share buyback of 82,900 shares at a maximum price of 15.67 yuan per share, totaling 1.29 million yuan, signaling recognition of the company's value and stability in stock price [2] - If Minsheng Health increases the buyback scale, it may further boost market confidence and solidify its long-term development foundation [2] Group 3 - Gaoguang Pharmaceutical has submitted its listing application to the Hong Kong Stock Exchange, with a post-C round financing valuation exceeding 2.462 billion yuan after raising 162 million yuan [3] - The company aims to accelerate research and development with capital support, although details on its core pipeline remain undisclosed [3] Group 4 - Yuekang Pharmaceutical plans to issue shares overseas (H shares) and list on the Hong Kong Stock Exchange to enhance its comprehensive competitiveness and international brand image [4] - This move aligns with the trend of globalization for pharmaceutical companies, and attention should be paid to the timing of the issuance and market feedback [4]

公告一出，炒股软件平台上，股民纷纷留言称赞。 根据本次回购方案，回购股份70%及以上将用于注销并减少注册资本。公司本次累计回购股份1.35亿股，其中9500万股将予以依法注销减少注册资本，注 销股份占注销前总股本比例为1.24%。 12月8日晚间，美的集团公告称，公司已完成以集中竞价交易方式回购公司部分已发行的A股股份，回购金额达100亿元，占回购方案的金额上限。 最新财报显示，美的集团前三季度实现营业总收入3647.2亿元，同比增长13.8%；归母净利润378.8亿元，同比增长19.5%。其中，仅第三季度，美的集团 营业总收入再次突破千亿达到1124亿元。截至2025年9月30日，股东总户数为30.87万户。 截至今日收盘，美的集团A股报81.81元/股 ，市值约为6296亿元。值得一提的是，美的集团在12月4日的盘中一度达83.17元，创下其近4年多来新高。 另据公开数据，截至11月底，A股市场已有1400余家上市公司实施股份回购，累计回购金额突破1300亿元大关。这一规模已达到A股历史上年度回购金额 的第二高水平，仅次于2024年（1658.77亿元）。 ...

2025年6月17日，美的集团通过回购专用证券账户，首次以集中竞价方式实施该次回购方案，回购股份数量为 207.81万股，占公司总股本的0.0271%，最高成交价为72.89元/股，最低成交价为72.02元/股，支付总金额为1.5亿 元。 此后，美的集团多次披露回购进展。 12月8日，美的集团公告表示，截至2025年12月8日，公司累计回购股份数量为1.35亿股，占公司总股本1.76%，最 高成交价为83.11元/股，最低成交价为69.91元/股，支付总金额约为100亿元。公司回购股份金额已达上述回购方案 金额上限100亿元，此次股份回购方案实施完毕。 不过，美的集团执行中的回购方案并不只这一份。除上述回购方案外，美的集团于2025年4月8日召开第五届董事 会第七次会议审议通过了《关于以集中竞价方式回购公司A股股份的方案》。按照该方案，美的集团拟回购15亿— 30亿元的公司股份。12月1日披露的公告显示，截至今年11月30日，美的集团已通过回购专用证券账户，以集中竞 价交易方式累计回购公司A股股份约2056.5万股，支付总金额约15亿元。 证券时报记者 吴志 历时半年，美的集团（000333）完成了百亿元股份 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000048 证券简称：京基智农 公告编号：2025-074 深圳市京基智农时代股份有限公司 2025年11月生猪销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 深圳市京基智农时代股份有限公司（以下简称"公司"）下属公司从事生猪养殖业务，根据《深圳证券交 易所上市公司自律监管指引第3号一一行业信息披露》的相关规定，现将公司每月生猪销售情况公告如 下： 一、2025年11月生猪销售情况 2025年11月，公司销售生猪20.23万头（其中仔猪1.88万头），销售收入3.01亿元；商品猪销售均价12.44 元/kg。 2025年1-11月，公司累计销售生猪211.13万头（其中仔猪30.93万头），累计销售收入34.64亿元。 上述销售数据未经审计，与定期报告披露的数据之间可能存在差异，因此上述数据仅作为阶段性数据供 投资者参考。 ■ 注：因四舍五入，以上数据可能存在尾差。 二、风险提示 （一）生猪养殖行业均面临生猪市场价格波动的风险。生猪市场价格的大幅波动，可能会对公司的经营 业绩产生重大影 ...

Core Viewpoint - The company, Xuzhou Helen Zhe Special Vehicle Co., Ltd., announced a share buyback plan to enhance employee stock ownership and incentivize long-term development, reflecting confidence in its future prospects [2]. Group 1: Buyback Details - The company plans to use its own funds to repurchase shares through centralized bidding, with a total buyback amount ranging from 50 million RMB to 100 million RMB, and a maximum buyback price of 7.50 RMB per share [2]. - At the upper limit of 100 million RMB, the estimated number of shares to be repurchased is approximately 1.33 million shares, representing about 1.32% of the total share capital [2]. - The buyback period will not exceed 12 months from the date of board approval [2]. Group 2: Financial Health - As of September 30, 2025, the company reported total assets of 2.639 billion RMB, current assets of 1.833 billion RMB, and net assets attributable to shareholders of 1.691 billion RMB [3]. - The buyback amount at the upper limit represents 3.79% of total assets, 5.46% of current assets, and 5.91% of net assets, indicating a low impact on financial metrics [3]. - The company's asset-liability ratio stands at 35.89%, reflecting a stable financial condition [3]. Group 3: Industry Perspective - The buyback is viewed as a strategic response to industry transformation, particularly as the specialized vehicle sector accelerates its shift towards new energy and smart technologies [3]. - The buyback is expected to enhance shareholder returns by reducing the number of circulating shares, thereby indirectly increasing earnings per share and improving stock liquidity and valuation in the secondary market [3]. - Overall, the buyback aligns with both short-term market confidence and long-term development goals, serving as a reference for other listed companies in the industry to improve incentive mechanisms and achieve sustainable growth [3].

Group 1 - Aerospace Power (航天动力) does not engage in commercial aerospace business and has no investments in commercial aerospace assets [1] - Changguang Huaxin (长光华芯) is in the early stages of overseas business development for optical chips [1] - Zhejiang Rongtai (浙江荣泰) plans to invest approximately $77 million in a production project in Thailand [1] Group 2 - Samsung Medical (三星医疗) is expected to win a bid for a procurement project from the State Grid worth 108 million yuan [1] - Guosheng Technology (国晟科技) intends to acquire 100% equity of Fuyue Technology for 241 million yuan [1] - Jinke Agricultural (京基智农) plans to repurchase shares worth between 100 million to 200 million yuan [1] Group 3 - Dongwei Technology (东威科技) shareholders plan to reduce their holdings by no more than 1.11% [2] - Hongde Shares (宏德股份) actual controller Yang Jinde plans to reduce his holdings by no more than 2.81% [2] Group 4 - LZ Group (立中集团) signed a procurement agreement for humanoid robot processing parts [3] - Tailong Pharmaceutical (太龙药业) plans to raise no more than 454 million yuan through a private placement to Jiang Pharmaceutical Holdings [3]

Group 1 - Midea Group has completed a share repurchase plan amounting to 10 billion yuan, marking the highest cumulative repurchase amount in A-shares history [1] - As of December 8, 2025, Midea Group has repurchased 135 million shares, accounting for 1.76% of the total share capital, with a total payment of approximately 9.999 billion yuan [1] - The repurchased shares will see 70% or more used for cancellation and reduction of registered capital, with 95 million shares set to be legally canceled [1] Group 2 - Midea Group's single repurchase amount of 10 billion yuan is the second-largest in A-share history, following Gree Electric's 15 billion yuan repurchase [2] - Cumulatively, Midea Group has repurchased a total of 39.2 billion yuan since its listing, leading all A-share companies [2][3] - Other companies with significant cumulative repurchase amounts include Gree Electric at 30 billion yuan, China State Construction at 13 billion yuan, and Baosteel at 13.1 billion yuan [3]

公告一出，炒股软件平台上，股民纷纷留言称赞。 每经编辑｜金冥羽 12月8日晚间，美的集团公告称，公司已完成以集中竞价交易方式回购公司部分已发行的A股股份，回购金额达100亿元，占回购方案的金额上限。 根据本次回购方案，回购股份70%及以上将用于注销并减少注册资本。公司本次累计回购股份1.35亿股，其中9500万股将予以依法注销减少注册资本，注 销股份占注销前总股本比例为1.24%。 （免责声明：文章内容和数据仅供参考，不构成投资建议。投资者据此操作，风险自担。） 编辑|||金冥羽 杜恒峰 校对|许绍航 封面图片来源：视觉中国 每日经济新闻综合自每经网、21财经、公开资料 最新财报显示，美的集团前三季度实现营业总收入3647.2亿元，同比增长13.8%；归母净利润378.8亿元，同比增长19.5%。其中，仅第三季度，美的集团 营业总收入再次突破千亿达到1124亿元。截至2025年9月30日，股东总户数为30.87万户。 截至今日收盘，美的集团A股报81.81元/股 ，市值约为6296亿元。值得一提的是，美的集团在12月4日的盘中一度达83.17元，创下其近4年多来新高。 另据公开数据，截至11月底，A股市场已有 ...

智通财经APP讯，京基智农(000048.SZ)公告，公司拟回购公司股份用于股权激励或员工持股计划。本次 拟回购股份的资金总额不低于1亿元，且不超过2亿元。回购股份的价格不超过23.70元/股(含)。回购股 份的实施期限自公司董事会审议通过本次回购股份方案之日起不超过6个月。 ...

证券时报·数据宝统计，酷派集团在港交所公告显示，12月8日以每股1.300港元至1.350港元的价格回购 342.00万股，回购金额达453.44万港元。该股当日收盘价1.330港元，下跌0.75%，全天成交额639.94万 港元。 自11月28日以来公司已连续7日进行回购，合计回购1846.80万股，累计回购金额2419.09万港元。 其间 该股累计上涨7.26%。 今年以来该股累计进行38次回购，合计回购5935.50万股，累计回购金额7529.31万港元。（数据宝） 酷派集团回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.08 | 342.00 | 1.350 | 1.300 | 453.44 | | 2025.12.05 | 414.40 | 1.360 | 1.300 | 557.25 | | 2025.12.04 | 205.20 | 1.340 | 1.310 | 272.74 | | 2025.12.03 | 254.80 | 1.320 | ...